Steve L. Hoerter

Mr. Hoerter has served as a member of the board of directors since August 2021. Mr. Hoerter currently serves as President and Chief Executive Officer of Deciphera Pharmaceuticals, a position he has held since March 2018. Prior to joining Deciphera, Mr. Hoerter served as the Chief Commercial Officer of Agios Pharmaceuticals from 2016 to 2019. From 2011 to 2015, Mr. Hoerter served as Senior Vice President, Commercial and from 2015 to 2016, as Executive Vice President and Chief Commercial Officer at Clovis Oncology.

Previously, he was General Manager and Management Center Head at Roche Group for the Sub-Saharan Africa and Indian Ocean Region. From 2005 to 2010, Mr. Hoerter held a variety of positions at Genentech, including serving on the senior leadership team for Genentech's bio-oncology business. Prior to joining Genentech, Mr. Hoerter held commercial roles at Chiron Corporation and Eli Lilly and Company in the United States, Europe and Africa. Mr. Hoerter has served on the board of directors of Deciphera since May 2018 and previously served on the board of directors of Constellation Pharmaceuticals, from September 2018 through its acquisition by MorphoSys AG in July 2021, and Ignyta from December 2016 through its acquisition by Roche Holding AG in February 2018. Mr. Hoerter holds a B.A. from Bucknell University, an M.B.A. from Tilburg University, and an M.S. in management from Purdue University.